1 study on Il 2 mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research highlights the profound potential of PASylation to significantly improve the therapeutic profile of immunomodulatory peptides like Thymosin α1, offering a long-acting formulation that could drastically r…